Ballsy Celgene Continues to Tread Carefully Into Neurosciences Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company made some bold moves this month in acquiring Juno and Impact Source: BioSpace You Might Also Like Athenex Moves Forward With $205M New York Plant January 11, 2018 GSK Is Now Favorite to Acquire Pfizer's Consumer Health Business March 21, 2018 Why Bluebird Bio Investors Aren't Singing the Blues December 12, 2017
